Table 3 Subject characteristics and results of planar whole-body radioactivity measurements for cohort 1. The height, weight and BMI (body mass index) are included to allow correlation between general measures of body habitus and the results from quantitative imaging
From: In vivo quantification of 177Lu with planar whole-body and SPECT/CT gamma camera imaging
Identifier | Primary Dx | Height (cm) | Weight (kg) | BMI (kg/m2) | Cycle | Administered (MBq) | Measured (MBq) | Difference (%) | Subject average difference (%) |
|---|---|---|---|---|---|---|---|---|---|
A | Small bowel NET | 170 | 66 | 23 | 1 | 6232 | 6378 | 2.3 | 5.8 |
2 | 8505 | 9327 | 9.7 | ||||||
3 | 7515 | 8215 | 9.3 | ||||||
4 | 7803 | 7956 | 2.0 | ||||||
B | Pancreatic NET | 177 | 88 | 28 | 1 | 6780 | 6494 | −4.2 | 2.9 |
2 | 8434 | 9110 | 8.0 | ||||||
3 | 8505 | 9060 | 6.5 | ||||||
4 | 7599 | 7708 | 1.4 | ||||||
C | Breast NET | 169 | 77 | 27 | 1 | 7985 | 7767 | −2.7 | 4.2 |
2 | 9096 | 9516 | 4.6 | ||||||
3 | 7996 | 8878 | 11.0 | ||||||
4 | 7821 | 8133 | 4.0 | ||||||
D | Rectal NET | 178 | 66 | 21 | 1 | 8711 | 9410 | 8.0 | 9.6 |
2 | 7614 | 8465 | 11.2 | ||||||
E | Small bowel NET | 150 | 79 | 35 | 1 | 7971 | 8542 | 7.2 | 4.4 |
2 | 7669 | 7689 | 0.3 | ||||||
3 | 7930 | 8392 | 5.8 | ||||||
4 | 8100 | 8012 | −1.1 | ||||||
F | Meningioma | 180 | 88 | 27 | 1 | 7928 | 8730 | 10.1 | 7.9 |
2 | 7560 | 8042 | 6.4 | ||||||
4 | 7900 | 8471 | 7.2 | ||||||
G | Meningioma | 168 | 68 | 24 | 1 | 7827 | 8529 | 9.0 | 6.0 |
2 | 7391 | 7923 | 7.2 | ||||||
3 | 7897 | 8036 | 1.8 | ||||||
H | Adrenal phaeochromocytoma | 175 | 69 | 23 | 1 | 7618 | 8127 | 6.7 | 6.3 |
2 | 7484 | 7925 | 5.9 | ||||||
I | Pancreatic NET | 183 | 93 | 28 | 1 | 7115 | 5898 | −17.1 | −4.0 |
3 | 8160 | 8902 | 9.1 | ||||||
Mean | 170.9 | 75.1 | 26.0 | 7841 | 8263 | 4.6 | |||
SD | 5.9 |